cholesterol REVERSING drug What would that sell a year, 5 to ten billion , with 60 % of Americans obese and rates climBING even in the developing world. This coud easily be swallowed up for 1 to billion. Its a paltry 12 month Internal rate of return in a "growth " industry..... OBESITY. A special thank you for SNOBEI ( Stock house user) for putting this on my screen. A true long term value play. 20 % of shares held by CEO, mucho options and NONE EXERCISED. US PHARMA AT MULTI YEAR HIGHS AND CASH RICH FOR PIPELINE DRUG ACQUISITIONS.